 |
|
|
| |
The global prevalence of resistance-associated substitutions (RAS) in "unusual" HCV subtypes
|
| |
| |
AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
S. Popping*, S. Fourati* , AYM Howe , A. de Salazar, VC Di Maio, ESE Tay, C. Rodrigo, E. Cunningham, M. Kjellin, J. Sfalcin, P. Gomes, M. Poljak, M. Lunar, M. Sayan, O. Mor, D. Salmon, R. Usubillaga, C. Seguin-Devaux, A. Soulier , A. Lloyd , J. Grebely, J. Lennerstrand, R. Kaiser, P. Zhigalkina, V. Chulanov, RJ de Knegt, M. Douglas, F. Ceccherini-Silberstein, R. Harrigan, F. Garcia ,C. Boucher, JM Pawlotsky
On behalf of the contributing members of the SHARED database
Surveillance of Hepatitis-C Antiviral Resistance, Epidemiology and methoDologies
Suboptimal SVR rates in African patients with atypical Genotype 1 subtypes:implications for global elimination of Hepatitis C
http://www.natap.org/2019/HCV/081319_01.htm
NATAP/EASLUnacceptably low SVR rates in African patients with unusual HCV sub-genotypes: Implications for global elimination - (04/18/19)
|
| |
|
|
|
|
|
